Cenata
Germany's Publicly Funded Insurance to Cover NIPT Under Limited Circumstances
Starting in late 2020, public health insurance is expected to pay for NIPT if a trisomy is suspected and this constitutes an "unacceptable burden" for the pregnant woman.
Streck Prevails in Roche Opposition to NIPT Blood Collection Tube European Patent
In addition, a German court found in December that German NIPT company Cenata infringes Streck's patent.
Streck Files Patent Suit Against NIPT Firm Cenata in Germany
Streck claims that the blood collection tubes in the Roche Ariosa Harmony kit that Cenata uses infringe its patent.
In Response to Illumina Patent Suit, Cenata Temporarily Outsources NIPT to Slovakian Lab
Until March 2018, when the patent in question expires, Cenata will have its Harmony test performed by Medirex in Slovakia.
Germany Weighs NIPT Reimbursement for High-Risk Pregnancies as Competition Between Labs Heats Up
Premium
Last week, the G-BA, a committee that decides about reimbursable medical services in Germany, said it will start a methods evaluation of noninvasive prenatal testing.